Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
64.7M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
58.3M
-
Shares change
-
+4.05M
-
Total reported value, excl. options
-
$537M
-
Value change
-
+$27.3M
-
Put/Call ratio
-
0.04
-
Number of buys
-
90
-
Number of sells
-
-83
-
Price
-
$9.21
Significant Holders of Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) as of Q2 2025
217 filings reported holding EOLS - Evolus, Inc. - Common Stock, par value $0.00001 per share as of Q2 2025.
Evolus, Inc. - Common Stock, par value $0.00001 per share (EOLS) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.3M shares
of 64.7M outstanding shares and own 90.16% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (5M shares), Nantahala Capital Management, LLC (4.2M shares), BlackRock, Inc. (4.18M shares), Caligan Partners LP (3.34M shares), VANGUARD GROUP INC (3.32M shares), PERCEPTIVE ADVISORS LLC (2.47M shares), Frazier Life Sciences Management, L.P. (2.44M shares), Soleus Capital Management, L.P. (2.12M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.66M shares), and MILLENNIUM MANAGEMENT LLC (1.48M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.